These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1086263)

  • 1. Studies on the subpopulation and function of peripheral lymphocytes, and inhibitor to PHA stimulation existing in the serum of patients with liver disease.
    Nakao M; Mizoguchi Y; Monna T; Yamamoto S; Morisawa S
    Gastroenterol Jpn; 1975; 10(4):307-15. PubMed ID: 1086263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of various indices of T and B immunity systems in patients with chronic hepatitis and liver cirrhosis].
    Epishina NA; Sytnik IA; Epishin AV
    Vrach Delo; 1983 Aug; (8):94-8. PubMed ID: 6605624
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of lymphocyte subpopulations by stimulation with polyclonal mitogens in chronic liver diseases].
    Nicolaescu T; Bordea M; Bordeianu A; Bittman E; Stoiculescu P; Udrescu E
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(2):167-74. PubMed ID: 6139862
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunological indicators in chronic hepatitis and liver cirrhosis].
    Podymova SD; Bon KU
    Sov Med; 1980; (12):38-41. PubMed ID: 6971495
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphocyte proliferation to phytohemagglutinin (PHA) in hepatitis B antigen-positive and -negative hepatitis.
    Sodomann CP; Rother M; Havemann K; Martini GA
    Res Exp Med (Berl); 1979 Apr; 175(1):95-107. PubMed ID: 441526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte transformation test with liver-specific protein and phytohaemagglutinin in patients with liver disease.
    Thestrup-Pedersen K; Ladefoged K; Andersen P
    Clin Exp Immunol; 1976 Apr; 24(1):1-8. PubMed ID: 949867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytotoxic activity of the lymphocytes in patients with chronic hepatitis and liver cirrhosis].
    Mokhov VM; Lisok TP; Petrov AL
    Ter Arkh; 1983; 55(2):43-5. PubMed ID: 6601859
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of PHA-stimulated lymphocyte transformation by plasma from patients with advanced alcoholic cirrhosis.
    Hsu CC; Leevy CM
    Clin Exp Immunol; 1971 May; 8(5):749-60. PubMed ID: 5581064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cellular immunity in patients with chronic liver diseases].
    Makolkin VI; Zozulia TV; Zolotnitskaia RP; Tananaeva IK
    Ter Arkh; 1981; 53(12):100-3. PubMed ID: 6977883
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lymphocytic reactivity to PHA in the course of diverse hepatic diseases].
    Poujoulet N; Dambrin G; Colombies P; Ducos J
    Ann Inst Pasteur (Paris); 1972 Jul; 123(1):117-8. PubMed ID: 4640712
    [No Abstract]   [Full Text] [Related]  

  • 11. [Indicators of cellular and humoral immunity in patients with chronic diffuse liver disease].
    Karashurova LL; Starkova SA
    Vrach Delo; 1985 Jan; (1):25-8. PubMed ID: 3872530
    [No Abstract]   [Full Text] [Related]  

  • 12. T and B lymphocytes in patients with chronic active hepatitis (CAH).
    Colombo M; Vernace SJ; Paronetto F
    Clin Exp Immunol; 1977 Oct; 30(1):4-9. PubMed ID: 304778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosette inhibition test in chronic liver disease.
    Salerno F; Fargion SR; Cappellini MD; Fiorelli G; Dioguardi N
    J Clin Pathol; 1976 Sep; 29(9):778-81. PubMed ID: 1086310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphocyte typing in chronic hepatopathies].
    Fargion SR; Cappellini MD; Malesci A; Ronchi G; Fiorelli G
    Minerva Gastroenterol; 1976; 22(3):245-50. PubMed ID: 1087386
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction in circulating T lymphocytes in alcoholic liver disease.
    Bernstein IM; Webster KH; Williams RC; Strickland RG
    Lancet; 1974 Aug; 2(7879):488-90. PubMed ID: 4137162
    [No Abstract]   [Full Text] [Related]  

  • 16. [Functional state of the T- and B-lymphocytes in children with chronic liver diseases].
    Mantasheva VA; Mikhaĭlova ZM; Chistova LV; Shkarenkova LV
    Pediatriia; 1980 Mar; (3):19-21. PubMed ID: 6966390
    [No Abstract]   [Full Text] [Related]  

  • 17. [T- and B-lymphocytes in lymphoproliferative diseases].
    Tsveibakh AS; Gol'dman EI
    Vopr Onkol; 1978; 24(1):11-6. PubMed ID: 305684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T and B lymphocytes in non-Hodgkin's lymphoma: a comparison of tumor-derived cells and peripheral blood lymphocytes.
    Noguchi S; Bukowski R; Deodhar S; Hewlett JS
    Cancer; 1976 May; 37(5):2247-54. PubMed ID: 1083288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The significance of immunological indicators in the diagnosis of chronic diseases of the liver].
    Iakhontova OI; Karashurova LL; Starkova SA
    Vrach Delo; 1988 Apr; (4):39-41. PubMed ID: 3261058
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lymphocyte transformation in chronic hepatitis and other hepatic diseases].
    Scheiffarth F; Warnatz H; Ottenjann R; Ritter H
    Arch Klin Med; 1969; 216(5):447-56. PubMed ID: 4984373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.